This clinical scenario, due to its complexity and particularities, offered multiple valuable research avenues regarding the molecular oncogenesis of BC (i.e., the apparent atypical involvement of the BRAF pathway), as well as the prediction of therapeutic response to immunotherapy. Here, BRAF is linked to breast cancer.